World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
117
Citations
47840
World Ranking
4223
National Ranking
2311

Jeffrey B. Kopp publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jeffrey B. Kopp sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 481 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jeffrey B. Kopp D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey B. Kopp sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 117 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Jeffrey B. Kopp is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on medicine, with a significant volume of work dedicated to nephrology, molecular biology, genetics, rheumatology, and immunology. The scientist has contributed extensively to the study of renal diseases and glomerulopathies, chronic kidney disease and diabetes, renal and related cancers, chronic lymphocytic leukemia research, systemic lupus erythematosus research, single-cell and spatial transcriptomics, and pregnancy and preeclampsia studies.

Their publication record includes several notable papers such as:

  • Podocytopathies, 2020, Nature Reviews Disease Primers
  • Development and evaluation of deep learning-based segmentation of histologic structures in the kidney cortex with multiple histologic stains, 2020, Kidney International
  • Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, 2022, Kidney International
  • COVID-19-Associated Collapsing Glomerulopathy: An Emerging Entity, 2020, Kidney International Reports
  • The key role of NLRP3 and STING in APOL1-associated podocytopathy, 2021, Journal of Clinical Investigation

Jeffrey B. Kopp has collaborated frequently with a number of coauthors, including Cheryl A. Winkler, Teruhiko Yoshida, Avi Z. Rosenberg, Khun Zaw Latt, and Shashi Shrivastav. The volume of these collaborations is notable, with each coauthor having contributed to multiple publications alongside Kopp.

The scientist's work has been published in various specialized venues. The most frequent publication venues include:

  • Journal of the American Society of Nephrology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Kidney International
  • UNC Libraries
  • American Journal of Kidney Diseases

Research undertaken by Jeffrey B. Kopp spans key areas in biochemistry, genetics, and molecular biology, with a focus on clinical and laboratory investigations related to kidney diseases. The range of main fields and subfields shows a broad approach towards understanding mechanisms at molecular and immunological levels as well as clinical manifestations in nephrology.

The scientist holds a membership in the Association of American Physicians, reflecting a recognized position within the medical scientific community.

Best Publications

  • Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

    Giulio Genovese;Giulio Genovese;David J. Friedman;Michael D. Ross;Laurence Lecordier

  • VEGF inhibition and renal thrombotic microangiopathy.

    Vera Eremina;J. Ashley Jefferson;Jolanta Kowalewska;Howard Hochster

  • Enzyme replacement therapy in Fabry disease: a randomized controlled trial.

    Raphael Schiffmann;Jeffrey B. Kopp;Howard A. Austin;Sharda Sabnis

  • Identification of renox, an NAD(P)H oxidase in kidney.

    Miklós Geiszt;Jeffrey B. Kopp;Péter Várnai;Thomas L. Leto

  • Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

    Nancy Sanderson;Valentina Factor;Peter Nagy;Jeffrey Kopp

  • APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy

    Jeffrey B. Kopp;George W. Nelson;Karmini Sampath;Randall C. Johnson;Randall C. Johnson

  • TGF-β and fibrosis

    Mary H. Branton;Jeffrey B. Kopp

  • MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

    Jeffrey B Kopp;Michael W Smith;George W Nelson;Randall C Johnson

  • Apoptosis in podocytes induced by TGF-β and Smad7

    Mario Schiffer;Markus Bitzer;Ian S.D. Roberts;Jeffrey B. Kopp

  • APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease

    Afshin Parsa;W. H Linda Kao;Dawei Xie;Brad C. Astor

  • CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility.

    Jeong M. Kim;Hui Wu;Gopa Green;Cheryl A. Winkler

  • Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course.

    Mary H Branton;Raphael Schiffmann;Sharda G Sabnis;Gary J Murray

  • Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease.

    Jeffrey B. Kopp;Valentina M. Factor;Miklos Mozes;Peter Nagy

  • Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease

    Kumar Sharma;Bethany Karl;Anna V. Mathew;Jon A. Gangoiti

  • Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator.

    Anita Cheruvanky;Hua Zhou;Trairak Pisitkun;Jeffrey B. Kopp

  • The Notch pathway in podocytes plays a role in the development of glomerular disease

    Thiruvur Niranjan;Bernhard Bielesz;Antje Gruenwald;Manish P Ponda

  • Research capacity. Enabling the genomic revolution in Africa

    Charles Rotimi;Akin Abayomi;Alash'le Abimiku;Victoria May Adabayeri

  • Crystalluria and Urinary Tract Abnormalities Associated With Indinavir

    J.B. Kopp;K.D. Miller;J.A.M. Mican;I.M. Feuerstein

  • Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States

    Chagriya Kitiyakara;Paul Eggers;Jeffrey B. Kopp

  • Association of Trypanolytic ApoL1 Variants with Kidney Disease in

    Giulio Genovese;David J. Friedman;Michael D. Ross

Frequent Co-Authors

Cheryl A. Winkler
Cheryl A. Winkler National Institutes of Health
Barry I. Freedman
Barry I. Freedman Wake Forest University
Martin R. Pollak
Martin R. Pollak Beth Israel Deaconess Medical Center
Carl D. Langefeld
Carl D. Langefeld Wake Forest University
Marguerite R. Irvin
Marguerite R. Irvin University of Alabama at Birmingham
Lawrence B. Holzman
Lawrence B. Holzman University of Pennsylvania
Mary Cushman
Mary Cushman University of Vermont
Donald W. Bowden
Donald W. Bowden Wake Forest University
Matthias Kretzler
Matthias Kretzler University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always require the traditional path of medical school. Many students explore related degrees and alternative healthcare roles that can be started quicker and sometimes with fewer requirements. For example, those with a non-nursing background can consider direct entry msn programs online which offer a fast-track into advanced nursing careers.

If you’re seeking an accessible route, some schools offer the easiest bsn program to get into, allowing you to begin your nursing education without the highly competitive admissions process. Alternatively, entering the healthcare field as a medical coder is another viable pathway. Many medical billing and coding schools that accept financial aid provide flexible learning options and financial support.

For licensed practical nurses, advancing their careers is also possible through lpn to rn programs without teas test, which streamline the transition to registered nursing roles. This diversity of degree and career opportunities makes it easier than ever to join the healthcare workforce and find a path suited to your interests and circumstances.

Best Scientists Citing Jeffrey B. Kopp

Trending Scientists

Recently Published Articles